Publications in collaboration with researchers from Clínica Universitaria de Navarra (21)

2023

  1. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Revista Espanola de Cardiologia, Vol. 76, Núm. 3, pp. 183-196

2022

  1. Reply to Leonard P. Bokhorst and Berdine L. Heesterman's Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled Trial. Eur Urol. 2022;82:441

    European Urology

  2. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Radiologia

2020

  1. Adaptation and validation of the ICU Mobility Scale in Spain

    Enfermeria Intensiva, Vol. 31, Núm. 3, pp. 131-146

2019

  1. Degree of implementation of preventive strategies for post-ICU syndrome: Multi-centre, observational study in Spain

    Enfermeria Intensiva, Vol. 30, Núm. 2, pp. 59-71

  2. Assessment of ion recombination correction and polarity effects for specific ionization chambers in flattening-filter-free photon beams

    Physica Medica, Vol. 67, pp. 176-184

2018

  1. Amyloid PET in neurodegenerative diseases with dementia

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 6, pp. 397-406

2017

  1. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, Núm. 9, pp. 1575-1587

2014

  1. Medicina nuclear en España: Alta tecnología 2013

    Revista Espanola de Medicina Nuclear e Imagen Molecular

2012

  1. Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer

    Brachytherapy, Vol. 11, Núm. 2, pp. 119-124

  2. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

  3. External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: Preliminary data on clinical outcome

    International Journal of Radiation Oncology Biology Physics, Vol. 82, Núm. 3

  4. Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer

    Head and Neck, Vol. 34, Núm. 8, pp. 1081-1088

2011

  1. Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy

    International Journal of Radiation Oncology Biology Physics, Vol. 79, Núm. 4, pp. 1158-1163

  2. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4

  3. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB)

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4

2010

  1. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer

    International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140

2008

  1. Comparison of gated SPECT with other imaging techniques used in cardiology

    Revista Espanola de Cardiologia Suplementos, Vol. 8, Núm. B

2002

  1. Positron emission tomography (PET) in oncology (Part I)

    Revista Espanola de Medicina Nuclear, Vol. 21, Núm. 1, pp. 41-60

  2. Positron emission tomography (PET) in clinical oncology (Part III)

    Revista Espanola de Medicina Nuclear, Vol. 21, Núm. 4, pp. 304-323